BIO-TECHNE Corp Operating Income Loss

• BIO-TECHNE Corp showed a decrease of -50.5% in Operating Income Loss from 2024 to 2025.
• This data is from BIO-TECHNE Corp's annual report (Form 10-K), filed with the SEC on August 22, 2025.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2010: $41.65 million | Q3 2010: $38.36 million | Q4 2010: $37.35 million | Q1 2011: $44.74 million | Q3 2011: $40.95 million | Q4 2011: $37.68 million | Q1 2012: $46.36 million | Q3 2012: $37.80 million | Q4 2012: $36.90 million | Q1 2013: $43.95 million | Q3 2013: $39.39 million | Q4 2013: $35.74 million | Q1 2014: $45.77 million | Q3 2014: $35.22 million | Q4 2014: $34.58 million | Q1 2015: $39.43 million | Q3 2015: $31.03 million | Q4 2015: $36.03 million | Q1 2016: $43.53 million | Q3 2016: $29.16 million | Q4 2016: $17.88 million | Q1 2017: $33.50 million | Q3 2017: $26.03 million | Q4 2017: $24.15 million | Q1 2018: $43.08 million | Q3 2018: $25.76 million | Q4 2018: $33.60 million | Q1 2019: $44.09 million | Q3 2019: $33.33 million | Q4 2019: $36.99 million | Q1 2020: $47.79 million | Q3 2020: $49.09 million | Q4 2020: $51.00 million | Q1 2021: $68.63 million | Q3 2021: $63.22 million | Q4 2021: $62.35 million | Q1 2022: $90.45 million | Q3 2022: $56.32 million | Q4 2022: $67.89 million | Q1 2023: $80.21 million | Q3 2023: $55.86 million | Q4 2023: $38.00 million | Q1 2024: $67.00 million | Q3 2024: $39.99 million | Q4 2024: $47.42 million | Q1 2025: $38.71 million | Q3 2025: $47.66 million | Q4 2025: $54.46 million.
• Over the full 17 years of available data (2009 to 2025), BIO-TECHNE Corp's Operating Income Loss has declined by 32.2%.
• Historical annual values: Fiscal year 2025: $102.26 million | Fiscal year 2024: $206.69 million | Fiscal year 2023: $298.94 million | Fiscal year 2022: $296.59 million | Fiscal year 2021: $237.30 million | Fiscal year 2020: $157.42 million | Fiscal year 2019: $146.72 million | Fiscal year 2018: $136.18 million | Fiscal year 2017: $120.58 million | Fiscal year 2016: $150.59 million | Fiscal year 2015: $147.02 million | Fiscal year 2014: $159.8 thousand | Fiscal year 2013: $158.5 thousand | Fiscal year 2012: $166.21 million | Fiscal year 2011: $163.06 million | Fiscal year 2010: $156.33 million | Fiscal year 2009: $150.78 million.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026